Apimeds Pharmaceuticals US, Inc. — PREM14C Filings
1 PREM14C filing on record
This page lists all PREM14C filings submitted to the SEC by Apimeds Pharmaceuticals US, Inc. (APUS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Apimeds Pharmaceuticals US, Inc. has filed 1 PREM14C document with the SEC since 2024. To view all SEC filings by Apimeds Pharmaceuticals US, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
3/A
4
4/A
424B4
425
8-A12B
8-K
8-K/A
CERT
CORRESP
DEFM14C
DRS
DRS/A
DRSLTR
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PREM14C
S-1
S-1/A
S-8
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| PREM14C | INFORMATION STATEMENT | 0001213900-26-005174 | Jan 16, 2026 | — |